from the United States Court of Appeals for the Third Circuit
See other cases from the Third Circuit.
Reply of petitioners Novo Nordisk Inc., et al. filed. (Distributed)
Brief of respondents Robert F. Kennedy, Secretary of Health and Human Services, et al. in opposition filed. (Resubmitted)
Brief of Robert F. Kennedy, Secretary of Health and Human Services, et al. in opposition not accepted for filing. (To be resubmitted - April 03, 2026)
Motion to extend the time to file a response is granted and the time is further extended to and including March 30, 2026.
Motion to extend the time to file a response from February 27, 2026 to March 30, 2026, submitted to The Clerk.
Brief amicus curiae of Teva Pharmaceuticals USA Inc. filed.
Brief amicus curiae of Chamber of Commerce of the United States of America filed.
Motion to extend the time to file a response is granted and the time is extended to and including February 27, 2026.
Motion to extend the time to file a response from January 28, 2026 to February 27, 2026, submitted to The Clerk.
Petition for a writ of certiorari filed. (Response due January 28, 2026)
Novo Nordisk Inc.; Novo Nordisk Pharma, Inc., Petitioner, represented by Ashley C. Parrish
Robert F. Kennedy, Secretary of Health and Human Services, et al., Respondent, represented by D. John Sauer
Chamber of Commerce of the United States of America, Amicus Curiae, represented by Kwaku Affawua Akowuah
Teva Pharmaceuticals USA Inc., Amicus Curiae, represented by Sean Marotta